Daniel Adunkwah: Reimagining Safety and Choice with Autologous Blood Transfusions
Daniel Adunkwah, Doctor of Medical Laboratory Science, Laboratory Manager at Presbyterian Health Services, shared a post on LinkedIn:
“Autologous Blood Transfusion: A Significant Moment in Patient Care and Choice
Recent developments within the community of Jehovah’s Witnesses have brought renewed attention to an important medical practice, autologous blood transfusion. With increasing openness toward members receiving their own blood, this approach is becoming even more relevant in clinical care and patient centered medicine.
Autologous blood transfusion involves collecting and reinfusing a patient’s own blood, either before surgery or during a medical procedure. It is a concept that continues to bridge medical innovation with individual beliefs and healthcare preferences.
1. Why this matters now
Autologous transfusion provides an option that aligns medical treatment with personal convictions. For many patients, especially those who have previously declined donor blood, this development offers a pathway to safer surgical care while respecting deeply held beliefs.
2. Clinical significance
From a clinical perspective, autologous blood transfusion reduces the risk of transfusion transmitted infections and eliminates compatibility concerns. It is particularly useful in surgeries where significant blood loss is expected, and it supports modern strategies in patient blood management.
3. The broader healthcare insight
This moment highlights something important in medicine, the need to continually adapt care to meet patients where they are. When clinical science and patient values work together, outcomes improve and trust in healthcare grows stronger.
Autologous blood transfusion reminds us that sometimes the safest and most acceptable solution is one that comes directly from the patient themselves.
Dr. Daniel Adunkwah
Doctor of Medical Laboratory Science”
Stay updated with Hemostasis Today.
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event
-
Sep 25, 2026, 05:47Omid Seidizadeh: Evolutionary Constraint and Population Variation Across Coagulation Genes
-
Sep 25, 2026, 05:40Gerald Bertrand: Presenting UMi-NGS Non-Invasive Foetal HPA Genotyping at DGTI 2026
-
Sep 25, 2026, 05:33Urge Congress to support the Sickle Cell Disease Comprehensive Care Act – ASH
-
Sep 25, 2026, 05:24Isabelle Mahé: Reduced-Dose Apixaban in Extended CAT Treatment
-
Sep 25, 2026, 05:15Maria Cherska: High Cholesterol Isn’t Always Diet or Lifestyle – Sometimes It’s Genetic